Event Session
Life Sciences and IPR: Orange Book & Biologic Patents at the PTAB
January 27, 2022 @ 1:00 PM EST
1:00 PM ET
January 27, 2022
Life Sciences and IPR: Orange Book & Biologic Patents at the PTAB
The USPTO has recently released a third report providing data on post-grant petitions filed at the PTAB against Orange Book and biologic patents. Although the report shows that such petitions represent only a small number of the petitions filed at the PTAB, namely 4% challenging Orange Book patents, and 2% challenging biologic patents, these IPRs challenge patents of high value. Our panel will discuss the pros and cons of using the PTAB as a forum to challenge these patents, why institution rates for such petitions remain low, and strategies or both petitioners and patent owners at the PTAB.
CLE Materials
Key Insights from the PTAB’s Updated Orange Book and Biologic Patent Study
The PTAB Puts Hatch-Waxman Defendants on Notice: File IPRs Early or Risk Fintiv Discretionary Denial
PTAB Trends: More Orange Book Patents Are Surviving the ‘Death Squad’
USPTO Orange Book Patent/Biologic Patent Study PDF
The USPTO has recently released a third report providing data on post-grant petitions filed at the PTAB against Orange Book and biologic patents. Although the report shows that such petitions represent only a small number of the petitions filed at the PTAB, namely 4% challenging Orange Book patents, and 2% challenging biologic patents, these IPRs challenge patents of high value. …
Session Speakers
Thank You to Our Sponsors!
